Longmont, CO, United States of America

Surendra Dawadi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 18.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):

Title: Surendra Dawadi: Innovator in Pharmaceutical Research

Introduction

Surendra Dawadi is a notable inventor based in Longmont, Colorado, recognized for his contributions to the field of pharmaceutical research. With two patents to his name, he specializes in developing innovative compounds aimed at treating diseases through modulation of phosphoinositide 3-kinase (PI3K).

Latest Patents

Dawadi's latest patents include formulations that function as allosteric chromenone inhibitors of PI3K. These compounds are designed to be useful in treating disorders linked to PI3K modulation. The patent disclosures relate to compounds of Formula (I) and their pharmaceutically acceptable salts, detailing methods for manufacturing and utilizing these innovative compounds in the medical field. This breakthrough demonstrates Dawadi’s commitment to advancing treatment options for various diseases.

Career Highlights

Currently, Surendra Dawadi is affiliated with Petra Pharma Corporation, where he continues to engage in cutting-edge research and development. His work focuses on discovering and optimizing therapeutic agents that can effectively target PI3K-related pathways, providing new avenues for treating complex diseases.

Collaborations

Throughout his career, Dawadi has collaborated with esteemed colleagues, including Erin Danielle Anderson and Sean Douglas Aronow. These partnerships underscore the collaborative spirit prevalent within the research community, allowing for the cross-pollination of ideas and techniques that drive innovation.

Conclusion

Surendra Dawadi's innovative work in the development of allosteric chromenone inhibitors of PI3K positions him as a key figure in pharmaceutical research. His ongoing contributions and collaborative efforts not only reflect his expertise but also enhance potential treatment protocols for diseases linked to PI3K modulation. As he continues to advance his research, the implications of his patents will likely have a significant impact on future medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…